E
Lyell Immunopharma, Inc. LYEL
$0.5854 -$0.0209-3.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -15.38% 36.00% -51.85% -95.38% -99.97%
Total Other Revenue -- -- -- -- --
Total Revenue -15.38% 36.00% -51.85% -95.38% -99.97%
Cost of Revenue -- -- -- -- --
Gross Profit -15.38% 36.00% -51.85% -95.38% -99.97%
SG&A Expenses 10.29% -24.11% -35.60% -30.01% -50.03%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -33.30% -150.00% -71.53% 15.37% 11.35%
Total Operating Expenses 4.52% -14.43% -21.83% -11.25% -6.46%
Operating Income -4.52% 14.45% 21.81% 11.16% -299.72%
Income Before Tax -262.62% 12.33% 28.30% 9.40% -530.34%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -262.62% 12.33% 28.30% 9.40% -530.34%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -262.62% 12.33% 28.30% 9.40% -530.34%
EBIT -4.52% 14.45% 21.81% 11.16% -299.72%
EBITDA -5.00% 15.04% 23.37% 12.13% -454.73%
EPS Basic -227.41% 14.04% 29.76% 11.07% -521.36%
Normalized Basic EPS 3.16% 14.23% 28.63% 56.98% -518.10%
EPS Diluted -227.41% 14.04% 29.76% 11.07% -521.36%
Normalized Diluted EPS 3.16% 14.23% 28.63% 56.98% -518.10%
Average Basic Shares Outstanding 10.74% 1.99% 2.08% 1.87% 1.34%
Average Diluted Shares Outstanding 10.74% 1.99% 2.08% 1.87% 1.34%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings